000			01614nam a2200145 4500
008			250718b |||||||| |||| 00| 0 eng d
100			_aPallavi Athavale
245			_aIN VITRO EVALUATION OF THE CYTOTOXICITY AND BIOCOMPATIBILITY OF VIDANGADI KSHARA ON LYMPHOMA CANCER CELLS
300			_app67-75
520			_aThe global leading cause of mortality is cancer, with approximately 10 million cancer-related deaths documented in 2020. Vidangadi kshara (VK), a formulation containing Vidanga, Chitraka, Shunthi, Ghrita, Saindhava and Vacha, is traditionally prescribed for Gulma (lump) and Pleeha vyadhi (spleenomegaly). This research aims to evaluate the potential cytotoxic effects and biocompatibility of Vidangadi kshara against lymphoma cells, while assessing its impact on normal cells.The Vidangadi kshara preparation followed classical methodologies and underwent quality analysis according to standard guidelines before being tested for anticancer properties using the tetrazolium-based MTT assay. In mouse fibroblast L929 cells, VK demonstrated cell viability results comparable to cisplatin. When administered at a dose of 1mg, VK exhibited cytotoxic activity against Daudi and Raji Burkitt lymphoma cells. The percentage of cell viability observed with VK treatment was similar to that achieved with cisplatin treatment.
654			_aVidangadi kshara _aLymphoma cells _abiocompatibility _acytotoxic action
700			_a Veena B. Kupatib
773	0		_0132135 _9113083 _aDhanashri S. Dhavale _tPHYTOCHEMICAL PROFILING AND GC-MS ANALYSIS OF AQUEOUS METHANOL FRACTION OF SEVYACHANDANADI LEPA
942			_cJA
999			_c132138 _d132138